Inhibitors of MAO-A are clinically used as antidepressants and anxiolytics [17, 18] while MAO-B inhibitors are used for the treatment of Parkinson’s disease and for symptoms associated with Alzheimer’s disease [19, 20]. Here, MAOA is linked to Parkinson disease.